logo
Plus   Neg
Share
Email

Colfax To Sell Its Air And Gas Handling Business To KPS Capital In $1.8 Bln Deal

Diversified technology company Colfax Corp. (CFX) agreed Thursday to sell its Air and Gas Handling business to KPS Capital Partners, LP for enterprise value of $1.80 billion, including $1.66 billion in cash consideration and $0.14 billion in assumed liabilities and minority interest, subject to customary closing adjustments.

The Air & Gas Handling business had about $90 million of segment operating profit and $200 million of adjusted EBITDA in the twelve months ended March 29, 2019.

This transaction will position Colfax to achieve its leverage target and pursue strategic bolt-on acquisitions in its Medical Technology and Fabrication Technology segments.

"This completes the strategic shift of our portfolio to diversify end-market exposure, reduce cyclicality, and increase profitability," said Matt Trerotola, President and Chief Executive Officer of Colfax.

Completion of the transaction is expected in the second half of 2019 and is subject to customary closing conditions and approvals. Colfax expects to report the Air & Gas Handling business as a discontinued operation in its future results.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Microsoft has delayed the worldwide launch of its Surface Earbuds till Spring 2020. The $249 wireless earbuds were originally expected to launch this year. The delay is a setback in Microsoft's attempt to compete with Apple's latest earbuds, AirPods Pro, which has a new design and features active noise cancellation. General Motors Co. (GM) is hiring for new workforce, after cutting about some 4,000 salaried employees early this year. According to Detroit Free Press, the auto giant is hiring for a new workforce as the company invests more money to develop electric and self-driving vehicles. Earlier this year,... Australia's Federal Court has ruled in favor of more than 1,000 women in a landmark class-action lawsuit against Johnson & Johnson after they suffered severe pain and complications from the healthcare giant's pelvic mesh implants. Johnson & Johnson and its subsidiary Ethicon were accused of hiding the risks of its pelvic mesh products.
Follow RTT
>